Home › Scleroderma › Maryland › Baltimore
Scleroderma clinical trials in Baltimore, MD
6 studies for Scleroderma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
RecruitingPhase 2
- Johns Hopkins Asthma and Allergy Center, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- Johns Hopkins Hospital, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Baltimore
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Johns Hopkins University School of Medicine, Baltimore
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Chicago, IL10 studies
- Ann Arbor, MI10 studies
- Houston, TX9 studies
- Durham, NC7 studies
- Boston, MA7 studies
- Los Angeles, CA7 studies
- Philadelphia, PA6 studies
- New Orleans, LA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
- Plantation, FL4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.